Strober, B.; Papp, K. A.; Flack, M.; Gu, Y.; Thompson, E. H.; Valdecantos, W. C. Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate-to-Severe Plaque Psoriasis. J of Skin 2017, 1, s10.